CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), announced today that it has signed a national agreement with UnitedHealthcare ...
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is ...
CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with ...
Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...
About 60% of all outstanding mortgages in Canada are expected to renew in 2025 or 2026. In this note, we provide an updated assessment of how mortgage payments may change for these households at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback